Hemostasis Today

April, 2026
April 2026
M T W T F S S
 12345
6789101112
13141516171819
20212223242526
27282930  
Nour Al-Mozain: Highlights on Therapeutic Plateletpheresis in Thrombocytosis
Apr 25, 2026, 04:10

Nour Al-Mozain: Highlights on Therapeutic Plateletpheresis in Thrombocytosis

Nour Al-Mozain, Hemopathologist, Consultant at King Faisal Specialist Hospital and Research Center, shared a post on LinkedIn about a  recent article she and her colleagues co-authored, published in Transfusion Medicine Reviews։

“Excited to share this collaborative important multicenter work on therapeutic plateletpheresis (TPP) in thrombocytosis, now published in Transfusion Medicine Reviews.

Highlights

  • TPP remains a safe, rapid but transient intervention, best utilized as a bridge in symptomatic thrombocytosis while awaiting cytoreductive therapy
  • Most patients treated had MPN-related thrombocytosis, often presenting with neurologic symptoms or thrombotic/bleeding complications.
  • While platelet reduction goals were commonly achieved, clear outcome benefit beyond count reduction remains uncertain

Clinical takeaway:

TPP should be used in a guideline-informed manner, with emphasis on clinical symptoms rather than platelet count alone, and always integrated within a broader cytoreductive strategy.”

Title: Therapeutic Plateletpheresis for Thrombocytosis: Critical Analytic Reviews and Original Multicenter Experience

Authors: Jensyn Cone Sullivan, Jay S. Raval, Nicole D. Zantek, David L. Allison, Gaurav Gupta, Caroline R. Alquist, Nour Al Mozain, Hlaing Tint, Louise Helander, Lisa Boggio, Jose Pérez-Carrillo, Kyle Annen

Nour Al-Mozain: Highlights on Therapeutic Plateletpheresis in Thrombocytosis

Find more posts featuring Nour Al-Mozain on Hemostasis Today.